A retrospective study of Infliximab and Adalimumab assessing drug and antibody levels for clinical decision making in patients with inflammatory bowel disease.
Phase of Trial: Phase IV
Latest Information Update: 26 Feb 2016
At a glance
- Drugs Adalimumab (Primary) ; Infliximab (Primary)
- Indications Inflammatory bowel diseases
- Focus Pharmacodynamics
- 26 Feb 2016 New trial record